Sensitive detection of EGFR mutations
The therascreen EGFR Plus RGQ PCR Kit is an in vitro diagnostic test to support your selection of NSCLC patients for therapy with EGFR tyrosine kinase inhibitors (TKIs), based on the detection of mutations in the EGFR gene (1).
Regular testing using liquid biopsy (plasma) samples can help to positively impact treatment outcomes, by ensuring patients get the right treatment at the right stage of their treatment journey.
therascreen EGFR Plus RGQ PCR Kit Instructions for Use. (March 2022).